PRAVASTATINE ZENTIVA 40 mg, tablet 28 tablets, CIP 3400927517792
Active ingredients: Pravastatin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Tablet28 tablets, CIP 3400927517792orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PRAVASTATINE ZENTIVA 40 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polychlortrifluoroéthylène PVDC aluminium de 28 comprimé(s) ( abrogée le 10/06/2025)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Mar 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60270452CIP72751779CIP133400927517792Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PRAVASTATINE SODIQUEcomprimé | 40 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.